$3.2 Billion Worldwide Medical Microbiology Testing Technologies Industry to 2027 – Impact of COVID-19 on the Market

    NEXT STORY
    NexImmune Completes Dosing of First Cohort in Phase 1/2 Clinical Trial of NEXI-001 in Relapsed Acute Myelogenous Leukemia (AML)
    PREV STORY
    Tampa General Hospital announces strategic partnership with Philips to innovate and improve patient experience
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Basilea announces license agreement with Pfizer for antifungal Cresemba® (isavuconazole) for Europe, Russia, Turkey and Israel

    Basilea receives a CHF 70 million upfront payment and is eligible for additional milestone ...

    author_avatar
    NASDAQ Market News

    Iterum Therapeutics Announces Topline Results from its Phase 3 Clinical Trial of Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections

    author_avatar
    NASDAQ Market News

    ENT and Allergy Associates(R) Sends Sound Waves through Middlesex County

    TARRYTOWN, N.Y., April 20, 2016 (GLOBE NEWSWIRE) -- Hearing loss and other diseases of ...

    author_avatar
    NASDAQ Market News